Bacterial cultivation from patient samples is the foundation of proper antibiotic treatment. A frequently used cultivation medium is agar with an additive of blood, so-called blood agar. The recommended additive of blood is horse blood while human blood is currently used as an additive at the microbiological laboratory Ryhov, Jönköping. The study aimed to evaluate horse blood in blood agar prior to a change in blood from human to horse blood according to a regulation from the European Union. The method consisted of cultivation from reference strains, clinical isolations and clinical patient samples on both blood agar with human blood and blood agar with horse blood. The comparison included a visual assessment for both blood agar based on the criteria of haemolysis, colony size and bacterial growth. In the assessment of clinical patient samples, in addition to the previously mentioned criteria, mixed flora was also assessed. The study resulted in a more distinct demonstration of haemolysis on blood agar with horse blood than on blood agar with human blood for haemolytic bacteria. An equivalence for both blood agar was presented regarding the remaining criteria. Based on these results a change can be made according to the regulation without negative impact.

<p style="text-align: justify;">Jedno od najvećih dostignuća u dvadesetom veku je bio pronalazak antibiotika i njihova primena u humanoj medicini. Međutim, vremenom se pokazalo da su izazivači bolesti mikroorganizmi koji &ldquo;uče&rdquo; i imaju sposobnost da se &ldquo;menjaju&rdquo;, &scaron;to neminovno dovodi do pojave antibiotske rezistencije, a čemu ide u prilog &scaron;iroko rasprostranjena upotreba antibiotika u lečenju pacijenata i primena humanih antimikrobnih lekova u veterini i fitofarmaciji. Razvoj novih i unapređenje postojećih farmaceutika zahteva ogromna ulaganja koja se mogu ali i ne moraju vratiti godinama. Prvi korak u razvoju novog farmaceutika je identifikacija ciljanog antibiotskog delovanja metabolita izabranog proizvodnog mikroorganizma, nakon čega sledi optimizacija uslova biosinteze u smislu sastava medijuma za proizvodnju.<br />Osnovni cilj ove doktorske disertacije je optimizacija formulacije medijuma za kultivaciju prirodnog izolata Streptomyces hygroscopicus u pogledu izvora makronutrijenata i njihovih količina, kako bi se metabolička aktivnost primenjenog proizvodnog mikroorganizma, u definisanim proizvodnim uslovima, usmerila ka sintezi antibiotika sa ciljanim delovanjem.<br />Optimizacijom formulacije medijuma za kultivaciju prirodnog izolata <em>Streptomyces hygroscopicus</em>, u primenjenim eksperimentalnim uslovima, odabrani su najpogodniji izvori makronutrijenata i definisane su njihove optimalne koncentracije za proizvodnju antibiotika sa ciljanim delovanjem. Utvrđeno je da je biosinteza baktericida efikasnih protiv <em>B. cereus</em> ATCC 10876, <em>S. aureus</em> ATCC 11632 i P. <em>aeruginosa</em> ATCC 27853 najizraženija u medijumu sa fruktozom, sojinim bra&scaron;nom i fosfatnim solima, dok je za dobijanje fungicida koji deluju na <em>C. albicans</em> ATCC 10231 i <em>A. niger</em> ATCC 16404 najadekvatnije primeniti medijum sa glukozom kao izvorom ugljenika i već pomenutim izvorima azota i fosfora pri čemu je odnos navedenih sastojaka medijuma specifičan za svaki test mikroorganizam. Sa tehnolo&scaron;kog aspekta, rezultati ovih istraživanja predstavljaju pouzdan izvor informacija za unapređenje proizvodnih karakteristika primenjenog biokatalizatora, izbor tehnike kultivacije, definisanje toka i optimizaciju postupka proizvodnje baktericida i fungicida sa krajnjim ciljem uvećanja razmera posmatranog bioprocesa.</p> / <p>One of the greatest achievements in the twentieth century was the invention of antibiotics and their application in human medicine. However, over time, it has been proven that disease susceptors are &quot;learning&quot; microorganisms and have the ability to &quot;change&quot;, which inevitably leads to the emergence of antibiotic resistance, which is in favor of widespread use of antibiotics in the treatment of patients and the application of human antibiotics in veterinary medicine and phytopharmacy. The development of new and the advancement of existing pharmaceuticals requires huge investments that may or may not be back for years. The first step in the development of a new pharmaceutical is the identification of the target antibiotic activity of the metabolite of the selected production microorganism, followed by the optimization of the conditions of biosynthesis in terms of composition of the production medium.<br />The main goal of this PhD thesis is the optimization of the formulation of the medium for the cultivation of the natural isolate Streptomyces hygroscopicus in terms of the source of macronutrients and their amounts, in order to direct the metabolic activity of the applied production microorganism, in the defined production conditions, towards the synthesis of antibiotics with targeted action. By optimizing the formulation of the medium for the culture of the natural isolate Streptomyces hygroscopicus, in the applied experimental conditions, the most suitable sources of macronutrients were selected and their optimal concentrations for the production of antibiotics with targeted action were defined. The biosynthesis of bactericides was found to be effective against B. cereus ATCC 10876, S. aureus ATCC 11632 and P. aeruginosa ATCC 27853 most pronounced in the medium with fructose, soy flour and phosphate salts, while for the production of fungicides acting on C. albicans ATCC 10231 and A. niger ATCC 16404 most appropriately apply a glucose medium as carbon source and already mentioned sources of nitrogen and phosphorus wherein the ratio of said ingredients to the medium is specific to each test microorganism. From a technological point of view, the results of these studies represent a reliable source of information for improving the production characteristics of the applied biocatalyst, a selection of cultivation techniques, defining the flow and optimizing the production of bactericides and fungicides with the ultimate goal of increasing the size of the observed bioprocess.</p>